Eti N. Sholikhah

Yogyakarta, YO, Indonesia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

N-aryl oleamides derived from indonesian palm oil as anticancer agents: from in silico design to synthesis and in vitro assay.

N-aryl oleamides derived from indonesian palm oil as anticancer agents: from in silico design to synthesis and in vitro assay.

Journal: Journal of computer-aided molecular design

Published: May 21, 2026

Allyl-functionalized calix[4]resorcinarenes against breast cancer cells: Synthesis, cytotoxicity, apoptosis induction, and computational insights.

Allyl-functionalized calix[4]resorcinarenes against breast cancer cells: Synthesis, cytotoxicity, apoptosis induction, and computational insights.

Journal: Bioorganic & medicinal chemistry letters

Published: October 01, 2025

Streptomyces GMR22 exhibits anti-Porphyromonas gingivalis activity and binding affinity toward gingipain K and dipeptidyl aminopeptidase IV.

Streptomyces GMR22 exhibits anti-Porphyromonas gingivalis activity and binding affinity toward gingipain K and dipeptidyl aminopeptidase IV.

Journal: Journal of Taibah University Medical Sciences

Published: July 16, 2025

Human strongyloidiasis in rural villages of South Kalimantan, Indonesia: A case series.

Human strongyloidiasis in rural villages of South Kalimantan, Indonesia: A case series.

Journal: Narra J

Published: July 04, 2025

Facing Moral Distress: Why We Need to Enhance Moral Resilience in Palliative Care Nursing.

Facing Moral Distress: Why We Need to Enhance Moral Resilience in Palliative Care Nursing.

Journal: Indian journal of palliative care

Published: June 05, 2025

Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation.

Rational Design of Chlorinated Hydroxyxanthone as Anticancer Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET, One-Pot Synthesis, and In Vitro Evaluation.

Journal: Cell biochemistry and biophysics

Published: May 28, 2025

The activity of pyrazoline B compound in inhibiting proliferation of breast cancer cells with human epidermal growth factor receptor 2 overexpression.

The activity of pyrazoline B compound in inhibiting proliferation of breast cancer cells with human epidermal growth factor receptor 2 overexpression.

Journal: Contemporary oncology (Poznan, Poland)

Published: May 25, 2025

Community Empowerment through Cadres in the Tuberculosis Program: A Scoping Review.

Community Empowerment through Cadres in the Tuberculosis Program: A Scoping Review.

Journal: Iranian journal of public health

Published: January 16, 2025

Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells.

Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells.

Journal: Journal of experimental pharmacology

Published: October 03, 2024

N-phenyl pyrazoline derivative inhibits cell aggressiveness and enhances paclitaxel sensitivity of triple negative breast cancer cells.

N-phenyl pyrazoline derivative inhibits cell aggressiveness and enhances paclitaxel sensitivity of triple negative breast cancer cells.

Journal: Scientific reports

Published: December 10, 2023

Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study.

Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study.

Journal: Advances and applications in bioinformatics and chemistry : AABC

Published: November 29, 2023

In Vitro Insulin Resistance Model: A Recent Update.

In Vitro Insulin Resistance Model: A Recent Update.

Journal: Journal of obesity

Published: November 10, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026